London College of Clinical Hypnosis University validated clinical hypnosis and hypnotherapy training London Taunton Birmingham Manchester Leeds Glasgow In partnership with the University of West London

Introduction to NLP Access Course - £49.50 (60% discount) [2156] Presented by: Bill Frost Neuro Linguistic Programming (NLP) is a personal philosophy and a large body of techniques that facilitate change. This course is designed to summarise the available tools and techniques, and will also seek to explain the philosophy that underpins them. This course is suitable for those with little or no experience of NLP that would like to learn more and will be as interactive as possible. Detailed notes (approx 45 pages) will be provided and software based multimedia tools to automate some NLP techniques will be demonstrated where feasible. You will learn... About NLP NLP Philosophy (The Pre-Suppositions) NLP Communications Model Primary Modalities (V/A/K) Meta Model Questioning Eye Accessing Cues Motivation And Goals NLP And Hypnosis (The Milton Model (A Model Of Hypnotic Language)) Techniques Overview (A top level overview of the many techniques available) The Swish Technique The Fast Phobia Technique Time Based Techniques (AKA Timeline Therapy) Thought Stopping Techniques Anchoring Sub Modality Shifts Appendices Sub Modality Shifts Anchoring Most of the most important NLP concepts and techniques are taught as part of the LCCH Hypnotherapy Training programme. Information will be available on the day for those interesting in pursuing their studies further. *Central London Sat 15 June 2013 10.00 AM to approx 5.00 PM University of London - Birkbeck Campus - Malet Street, Malet Building, WC1E 7HX: Room G16 £49.50 (Discounted by 60%, the normal masterclass fee is £125)

OMA BOARD MEETINGS NOT OPEN TO OMA MEMBERS

The OMA Board meetings are closed to OMA members. In Ontario the public can see the Legislative  assembly and Courts at work. Also College pf Phys & Surgeons Tribunals and Council meetings are open to the ;public. HSARB Tribunals are also open to the public. The OMA Board meet in secret. No reason given. Attendance figures are also secret.

J.CLIN.ONCOL.:MRI & MULTIPLE MYELOMA

Search

Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement.

Authors

Dimopoulos MA¹, Hillengass J², Usmani S², Zamagni E², Lentzsch S², Davies FE², Raje N², Sezer O², Zweegman S², Shah J², Badros A², Shimizu K², Moreau P², Chim CS², Lahuerta JJ², Hou J², Jurczyszyn A², Goldschmidt H², Sonneveld P², Palumbo A², Ludwig H², Cavo M², Barlogie B², Anderson K², Roodman GD², Rajkumar SV², Durie BG², Terpos E².

Author information

Journal

J Clin Oncol. 2015 Jan 20. pii: JCO.2014.57.9961. [Epub ahead of print]

Affiliation

Abstract

PURPOSE: The aim of International Myeloma Working Group was to develop practical recommendations for the use of magnetic resonance imaging (MRI) in multiple myeloma (MM).

METHODS: An interdisciplinary panel of clinical experts on MM and myeloma bone disease developed recommendations for the value of MRI based on data published through March 2014.

RECOMMENDATIONS: MRI has high sensitivity for the early detection of marrow infiltration by myeloma cells compared with other radiographic methods. Thus, MRI detects bone involvement in patients with myeloma much earlier than the myeloma-related bone destruction, with no radiation exposure. It is the gold standard for the imaging of axial skeleton, for the evaluation of painful lesions, and for distinguishing benign versus malignant osteoporotic vertebral fractures. MRI has the ability to detect spinal cord or nerve compression and presence of soft tissue masses, and it is recommended for the workup of solitary bone plasmacytoma. Regarding smoldering or asymptomatic myeloma, all patients should undergo whole-body MRI (WB-MRI; or spine and pelvic MRI if WB-MRI is not available), and if they have > one focal lesion of a diameter > 5 mm, they should be considered to have symptomatic disease that requires therapy. In cases of equivocal small lesions, a second MRI should be performed after 3 to 6 months, and if there is progression on MRI, the patient should be treated as having symptomatic myeloma. MRI at diagnosis of symptomatic patients and after treatment (mainly after autologous stem-cell transplantation) provides prognostic information; however, to date, this does not change treatment selection.

© 2015 by American Society of Clinical Oncology.

PMID

25605835 [PubMed - as supplied by publisher]

CAPIO UK Swedbank House 4th Floor 42 New Broad Street London EC2M 1SB Contact: Sarah Gillson, CommunicationCapio is a leading healthcare provider in Europe and supplies services within several medical specialities. Capio´s ambition is to be the healthcare provider that in the best way possible fulfils the demands of our patients, the public healthcare as well as from companies and organisations. That is why we focus on high quality and effective care services with the individual patient's needs and expectations in the centre. Instead of traditional competition, Capio has chosen to collaborate with public healthcare. In close co-operation with healthcare purchasers, principles, methods, models and concepts are developed that create innovative working practices. The Capio Group comprises more than 100 operating units with some 16,000 employees. Capio currently operates in Sweden, Norway, Denmark, Finland, France, the UK, Spain and Switzerland with an annual turnover rate of more than SEK 11, 000 M. Customers are public sector purchases, businesses as well as public and private insurance companies that buy healthcare services. - See more at: http://www.healthcare-today.co.uk/organisation.php?id=3#sthash.0PjBJIit.dpuf

• News Feeds
• Sources
• Free e-News
• Link
• Google+
• Facebook
• Twitter
• RSS

Organisations

   0  0

Capio Healthcare UK

Swedbank House
4th Floor
42 New Broad Street
London
EC2M 1SB

Contact: Sarah Gillson, Communications Manager
Sub-category: Company - Other

Profile

Press Releases

News

Events

Vacancies

ADS

Capio is a leading healthcare provider in Europe and supplies services within several medical specialities. Capio´s ambition is to be the healthcare provider that in the best way possible fulfils the demands of our patients, the public healthcare as well as from companies and organisations. That is why we focus on high quality and effective care services with the individual patient's needs and expectations in the centre.
Instead of traditional competition, Capio has chosen to collaborate with public healthcare. In close co-operation with healthcare purchasers, principles, methods, models and concepts are developed that create innovative working practices.
The Capio Group comprises more than 100 operating units with some 16,000 employees.
Capio currently operates in Sweden, Norway, Denmark, Finland, France, the UK, Spain and Switzerland with an annual turnover rate of more than SEK 11, 000 M.
Customers are public sector purchases, businesses as well as public and private insurance companies that buy healthcare services.

- See more at: http://www.healthcare-today.co.uk/organisation.php?id=3#sthash.0PjBJIit.dpuf

• News Feeds
• Sources
• Free e-News
• Link
• Google+
• Facebook
• Twitter
• RSS

Organisations

   0  0

Capio Healthcare UK

Swedbank House
4th Floor
42 New Broad Street
London
EC2M 1SB

Contact: Sarah Gillson, Communications Manager
Sub-category: Company - Other

Profile

Press Releases

News

Events

Vacancies

ADS

Capio is a leading healthcare provider in Europe and supplies services within several medical specialities. Capio´s ambition is to be the healthcare provider that in the best way possible fulfils the demands of our patients, the public healthcare as well as from companies and organisations. That is why we focus on high quality and effective care services with the individual patient's needs and expectations in the centre.
Instead of traditional competition, Capio has chosen to collaborate with public healthcare. In close co-operation with healthcare purchasers, principles, methods, models and concepts are developed that create innovative working practices.
The Capio Group comprises more than 100 operating units with some 16,000 employees.
Capio currently operates in Sweden, Norway, Denmark, Finland, France, the UK, Spain and Switzerland with an annual turnover rate of more than SEK 11, 000 M.
Customers are public sector purchases, businesses as well as public and private insurance companies that buy healthcare services.

- See more at: http://www.healthcare-today.co.uk/organisation.php?id=3#sthash.0PjBJIit.dpuf

CAPIO AB: : PRIVATE MEDICINE FRANCE,GERMANY, NORWAY, SWEDEN

This is Capio

Last updated

22 Jan, 2015 15:39

The Capio Group is one of Europe’s leading healthcare companies.

Via our hospitals, specialist clinics and primary care units we offer a broad range of medical, surgical and psychiatric healthcare of high quality.

Our operations and 11,875 employees¹ are located in four countries*. In 2013 we received more than 4.3 million patient visits².
Sweden
One emergency hospital, two local hospitals, 24 centres for specialist care, 21 centres for psychiatric care and 78 centres for primary care.
Norway
Six medical centres and three specialist clinics, for example within eating disorders.
France
Seven emergency hospitals, 12 local hospitals and three specialist clinics primarily
for such areas as dialysis, rehabilitation and psychiatry.
Germany
Four local emergency hospitals, five specialist clinics, two hospitals with rehabilitation
and care facilities, and six outpatient clinics.

  

¹ Number of employees as full-time equivalents on average during 2013.
² Number of inpatient and outpatient visits in 2013.

* In July 2014 Capio UK (Capio Nightingale hospital) was divested. In 2013 Capio UK received approximately 20,000 patient visits and contributed to Group net sales with 121 MSEK. Investments in Capio UK during 2013 were 31 MSEK and the number of employees (FTE) was 167.

UK INDEPENDENT DOCTORS FEDERATION (not in NHS)

History of the IDF

The IDF was started in 1989 under the name Independent Doctors Forum and it incorporated as a company limited by guarantee in 1992.  It was set up by a group of conscientious, like-minded and enthusiastic doctors working fulltime in the independent sector, who felt a platform was needed for open discussion, voicing ideas and exchanging views.
Since that time the IDF has grown in stature and significance and has taken on roles which far exceed the boundaries initially envisaged.  This has been particularly true with the introduction of appraisal and revalidation and its implications for member doctors.  It is also lobbying hard to make sure that the voice of the independent sector is heard within government, DOH, GMC, CQC.
Although aptly describing the initial aims of the group it was felt that the word Forum no longer fitted with the IDF's changing role and at a General Meeting held on 11th June 2009 members voted to change the company name from Independent Doctors Forum to Independent Doctors Federation. 
Membership of the IDF currently stands at just under 1200 - these are all GMC registered doctors in Independent Practice.  Members are currently split 2/3 Consultants; 1/3 GPs. We also have 46 corporate sponsors. 
To download a copy of the IDF's most recent accounts please click here. 

TORONTO FREE CONFERENCE (inc.lunch) HEALTH & HIGH POLITICS @ MUNK SCHOOL of GLOBAL AFFAIRS

Health & High Politics: The modern state’s interest in health equity & security

Saturday, January 31, 10:00 AM - 5:30 PM
Sponsored by: International Relations Society, Munk School of Global Affairs, Arts and Science Student Union, University of Toronto Student Union, Trinity College
Register online at:
http://munkschool.utoronto.ca/event/17682
The Vivian and David Campbell Conference Facility, 1 Devonshire Place

(Comment: Hopefully some of the elected OMA BOARD will attend together with some of the 250 OMA staff).